fingolimod hydrochloride has been researched along with Adenoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bueno, V; Cordeiro, JA; Cury, PM; Oshima, CT; Salinas, NR | 1 |
Bueno, V; Lopes, CT; Oshima, CT; Palma, PV; Salinas, NR | 1 |
2 other study(ies) available for fingolimod hydrochloride and Adenoma
Article | Year |
---|---|
FTY720 and lung tumor development.
Topics: Adenoma; Animals; Fingolimod Hydrochloride; Immunosuppressive Agents; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Proliferating Cell Nuclear Antigen; Propylene Glycols; Sphingosine; Urethane; Vascular Endothelial Growth Factor A | 2009 |
Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720.
Topics: Adenoma; Animals; Apoptosis; Caspase 3; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Lung; Lung Neoplasms; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Proliferating Cell Nuclear Antigen; Propylene Glycols; Sphingosine; Urethane | 2009 |